Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02694666 · ClinicalTrials.gov registry record · NA
Vibration Training for Preventing Falls in Healthy Population and Multiple Sclerosis
A NA study, sponsored by Georgia State University.
- Terminated
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT02694666: Clinical Trial NA study, sponsored by Georgia State University.
NCT02694666 is a NA study that was terminated before completion, run by Georgia State University. The registered enrollment target is 58 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02694666, a NA study, was terminated before completion, sponsored by Georgia State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
This study is to investigate the effects of controlled whole-body vibration training on reducing the likelihood of falls among healthy population and people with multiple sclerosis. (NOTE: research not covered by sponsored funding)
Primary Outcome
Real life falls are monitored for 12 months.
Interventions
- OTHER Controlled whole-body vibration training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2016-04 |
| Est. Completion | 2023-04-10 |
| Phase | NA |
Why NCT02694666 stopped before completion
NCT02694666 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Controlled whole-body vibration training is the first listed.
NCT02694666 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02694666 about?
NCT02694666 is a clinical study titled "Vibration Training for Preventing Falls in Healthy Population and Multiple Sclerosis". This study is to investigate the effects of controlled whole-body vibration training on reducing the likelihood of falls among healthy population and people with multiple sclerosis. (NOTE: research not covered by sponsored funding)
What is the current status of trial NCT02694666?
This trial is currently terminated. It is a NA study. The enrollment target is 58 participants. The study started on 2016-04. Estimated completion is 2023-04-10.
What interventions are being tested in trial NCT02694666?
The interventions under investigation include: Controlled whole-body vibration training (OTHER).
Who is sponsoring clinical trial NCT02694666?
This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02694666's enrollment target sits among peer trials
58 1256th of 2000 higher than 740 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia